Design Therapeutics, Inc. (DSGN) Earnings
|
Expand Research on DSGN
| Next EPS Date | 5/6/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +36.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +13.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/6/24 | Q124 | N/A | -$0.33 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/7/24 | Q423 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/24 | Q423 | -$0.21 | -$0.31 | +$0.10 | N/A | N/A | N/A |  | | Details | |
| 3/11/24 | Q423 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/23 | Q223 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A |
